|
Report Date : |
10.04.2014 |
IDENTIFICATION DETAILS
|
Name : |
TENTH OF RAMADAN
FOR PHARMACEUTICAL INDUSTRIES & DIAGNOSTIC REAGENTS (RAMEDA) |
|
|
|
|
Registered Office : |
2nd
Industrial Zone, Plot No.5, Street No. 20, Giza, 6th
of October City |
|
|
|
|
Country : |
Egypt |
|
|
|
|
Financials (as on) : |
31.12.2013 |
|
|
|
|
Year of Establishments: |
1986 |
|
|
|
|
Com. Reg. No.: |
84008, 6th of October City |
|
|
|
|
Legal Form : |
Egyptian Joint Stock Company |
|
|
|
|
Line of Business : |
manufacturer of pharmaceuticals and diagnostic chemicals. |
|
|
|
|
No. of Employees |
approximately
650 |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
No Complaints |
|
|
|
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – december 01, 2013
|
Country Name |
Previous Rating (30.09.2013) |
Current Rating (01.12.2013) |
|
Egypt |
B1 |
B1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
Egypt ECONOMIC OVERVIEW
Occupying the northeast corner of the African continent, Egypt is
bisected by the highly fertile Nile valley, where most economic activity takes place.
Egypt's economy was highly centralized during the rule of former President
Gamal Abdel NASSER but opened up considerably under former Presidents Anwar
EL-SADAT and Mohamed Hosni MUBARAK. Cairo from 2004 to 2008 aggressively
pursued economic reforms to attract foreign investment and facilitate GDP
growth. Despite the relatively high levels of economic growth in recent years,
living conditions for the average Egyptian remained poor and contributed to
public discontent. After unrest erupted in January 2011, the Egyptian
Government backtracked on economic reforms, drastically increasing social
spending to address public dissatisfaction, but political uncertainty at the
same time caused economic growth to slow significantly, reducing the
government's revenues. Tourism, manufacturing, and construction were among the
hardest hit sectors of the Egyptian economy, pushing up unemployment levels,
and economic growth is likely to remain slow amid political uncertainty. Cairo
since 2011 has drawn down foreign exchange reserves and depended on foreign
assistance to finance imports and prevent further devaluation of the Egyptian
pound, fearing higher inflation from a weaker currency.
|
Source : CIA |
Company Name :
TENTH OF RAMADAN FOR PHARMACEUTICAL INDUSTRIES &
DIAGNOSTIC REAGENTS (RAMEDA)
Country of Origin : Egypt
Legal Form : Egyptian Joint Stock Company
Registration Date : 1986
Commercial Registration Number : 84008, 6th of October City
Tax Card Number : 100-330-096
Issued Capital : £E 200,000,000
Paid up Capital : £E 200,000,000
Total Workforce : 650
Activities : Manufacturers of pharmaceuticals and diagnostic chemicals.
Financial Condition : Good
Payments : Nothing detrimental uncovered
Operating Trend : Steady
TENTH OF RAMADAN FOR PHARMACEUTICAL INDUSTRIES & DIAGNOSTIC REAGENTS (RAMEDA)
Registered &
Physical Address
Location : 2nd
Industrial Zone, Plot No.5, Street No. 20
Area : Giza
Town : 6th
of October City
Country : Egypt
Telephone : (20-2) 38331848
/ 38331849 / 38331766 / 38331773 / 38331887
Facsimile : (20-2) 38335606
/ 38331766 / 38331849
Mobile : (20-100) 1015501
Email : adibkh2000@yahoo.com
Premises
Subject operates
from a suite of offices and a factory covering an area of 33,000 square metres
that are owned and located in the Industrial Area of the 6th of October City.
Branch Office
(s)
Location Description
·
40 A Mohamed Mazhar Street Rented
office premises
Zamalek
Cairo
Tel: (20-2)
27382190 / 27382191
Fax: (20-2) 27355534
·
8
Gezert El Arab Street Rented office premises
Mohandessin, Giza
Cairo
Tel: (20-2) 37613048 / 37613058
Fax: (20-2) 37613018
Name Position
·
Ayman Mamdouh Abbas Chairman
·
Amr Abdallah Moursy Managing
Director
·
Shamel
Fahim Chief
Executive Officer
·
Dr Amer Adib Morsi General
Manager
·
Dr Adeeb Khalil Finance
Manager
·
Tarek Gharib Accounts
Manager
·
Dr Mohamed Moustafa Baraai Factory
Manager
·
Hefny Ahmed Administration
Manager
·
Ahmed Abdul Aal Human
Resources Manager
Date of Establishment : 1986
Legal Form :
Egyptian Joint Stock
Company
Commercial Reg. No. : 84008, 6th
of October City
Tax
Card No. : 100-330-096
Issued Capital : £E 200,000,000
Paid up Capital : £E 200,000,000
Name of Shareholder
(s)
·
Raya Holding for Technology &
Communication
Cairo
·
Cravel Limited
United
Kingdom
·
Sayed Shamel
Fahim Abu El Fadl
Activities: Engaged in the
manufacture of pharmaceuticals and diagnostic chemicals.
The following is a list of
licensing companies:
1. Alcon International (Belgium)
2. Axcan Pharma (Canada)
3. Laboratoire du Docteur Bouchara (France)
4. Krka Novomeisto (Slovenia)
A. Sterile areas for the
production of:
1. Eye Drops: (12.000.000 unit annual capacity) where the products of the
leading pharmaceutical company (Alcon) are manufactured according to the latest
technology in this field.
2. Injectable Cephalosporins:
(12.000.000 unit annual capacity)
Where our range of injectables is produced by the most sophisticated technology
in this field.
B. Production Lines for:
• Solid Forms: (Tablets, Capsules, Powders).
• Liquid Forms: (Syrup & Suspensions).
• Dermatologicals: (Ointment, Cream, Gel).
• Diagnostics.
Import
Countries: United States of
America, Japan and India.
Export
Countries: Yemen, Iraq, Libya and Somalia.
Operating Trend: Steady
Subject has a
workforce of approximately 650 employees.
Financial
highlights provided by local sources are given below:
Currency: Egyptian
Pounds (£E)
Year
Ending 31/12/12: Year Ending
31/12/13:
Total Sales £E 94,500,000 £E 97,250,000
Local sources
consider subject’s financial condition to be Good.
The above financial
figures are based on estimations by our local sources.
·
National
Bank of Egypt
24 Sherif Street
Cairo
Tel: (20-2) 33924175
Fax: (20-2) 33924143
·
Commercial
International Bank (CIB)
Nile Tower Building
21-23 Giza Street
PO Box: 2430
Cairo
Tel: (20-2) 25703043
Fax: (20-2) 25703172 / 25072691
·
Arab
Bank Plc
PO Box: 68
Cairo
Tel: (20-2) 33029069 / 33029070
Fax: (20-2) 33029068
No complaints
regarding subject’s payments have been reported.
Local sources
report that the subject’s operating history is clear with payment obligations
met in a generally timely manner. The financial position is satisfactory and
the company is deemed a fair trade risk.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.60.07 |
|
UK Pound |
1 |
Rs.100.56 |
|
Euro |
1 |
Rs.82.79 |
INFORMATION DETAILS
|
Analysis Done by
: |
DIV |
|
|
|
|
Report Prepared by
: |
MNL |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
|
56-70 |
A |
Financial & operational base are regarded healthy. General unfavourable
factors will not cause fatal effect. Satisfactory capability for payment of
interest and principal sums |
Fairly Large |
|
|
41-55 |
Ba |
Overall
operation is considered normal. Capable to meet normal commitments. |
Satisfactory |
|
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with full
security |
|
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
|
-- |
NB |
New Business |
-- |
|
This score serves as a reference to assess SC’s
credit risk and to set the amount of credit to be extended. It is calculated
from a composite of weighted scores obtained from each of the major sections of
this report. The assessed factors and their relative weights (as indicated
through %) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend (10%) Operational size
(10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or
its officials.